BforCure is a French SME of 66 people created in 2018, based in Montreuil (93, Ile de France).
It is revolutionizing bio-detection technologies with the ultimate goal of making our planet a safer place, protecting us against biological threats.
The company designs, manufactures, and commercializes innovative ultra-fast and sensitive PCR biosensing solutions.
Recognized and supported by key innovation players, BforCure develops technological platforms through an ambitious R&D program, challenging the state of the art in biodetection methods. Microfluidics technology is at the heart of BforCure products, which serve in various fields such as medical diagnostics, defense, industry, and environmental protection.
